1. CCR8 expression may be linked to disease severity and elevated IL-6 secretion in acute pancreatitis. (2021) Authors: Nalisa, M.; Nweke, E.; Smith, M.; Augustine, T.; Metzger, R.; Devar, J.; Omoshoro- Jones, J.; Fru, P. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S1012 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating cell free DNA levels when considered in isolation have little clinical value in patients with pancreatic ductal adenocarcinoma compared to other chronic diseases. (April 2016) Authors: Brand, M.; Dickens, C.; Omoshoro-Jones, J.; Devar, J.; Candy, G.; Smith, M.; Duarte, R. Journal: HPB Issue: Volume 18(2016)Supplement 1 Page Start: e357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Circulating Interleukin-6 in the Second Phase of Severe Acute Pancreatitis May Inform Early Management Strategies in a South African Patient Cohort. (2022) Authors: Fru, P.; Maimela, M.; Omoshoro-Jones, J.; Devar, J.; Smith, M. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of the Risk Factors and Initial Presenting Symptoms to the Stage of Disease in Pancreatic Ductal Adenocarcinoma at Chris Hani Baragwanath Academic Hospital. (2021) Authors: Lahoud, N.; Smith, M.; Devar, J.; Kruger, D. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Complement Protein Levels Decrease with Tumour Severity in Pancreatic Ductal Adenocarcinoma. (2022) Authors: Nsingwane, Z.; Elebo, N.; Mhlambi, N.; Devar, J.; Omoshoro-jones, J.; Smith, M.; Candy, G.; Nweke, E.E. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Expression of complement proteins C3 & C5 in South African pancreatic ductal adenocarcinoma patients and their potential roles in PDAC progression. (2021) Authors: Nsingwane, Z.; Candy, G.; Devar, J.; Omoshoro, J.; Mhlambi, N.; Elebo, N.; Smith, M.; Nweke, E. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S797 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Expression of Immune Markers in South African Pancreatic Ductal Adenocarcinoma Patients. (2022) Authors: Elebo, N.; Nsingwane, Z.; Fru, P.; Omoshoro-Jones, J.; Devar, J.; Smith, M.; Candy, G.; Nweke, E. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Identification of differentially expressed genes and associated immune cell types in South African gallbladder cancer patients. (2021) Authors: Devar, J.; Smith, M.; Nweke, E. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S757 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Identification of Diffrentially Expressed Genes and Associated Immune Cell Types in South African Gallbladder Cancer Patients. (2022) Authors: Devar, J.; Nweke, E.; Smith, M.; Mpangase, P. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immune response is inhibited in early pancreatic ductal adenocarcinoma by several mechanisms in a cohort of African patients. (2020) Authors: Nweke, E.; Mhlambi, N.; Nsingwane, Z.; Devar, J.; Smith, M.; Ntwasa, M.; Brand, M.; Omoshoro-Jones, J.; Candy, G. Journal: HPB Issue: Volume 22(2020)Supplement 2 Page Start: S270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗